کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6261925 | 1613270 | 2012 | 14 صفحه PDF | دانلود رایگان |

Traumatic brain injury (TBI) is a major public-health problem for which mild TBI (MTBI) makes up majority of the cases. MTBI is a poorly-understood health problem and can persist for years manifesting into neurological and non-neurological problems that can affect functional outcome. Presently, diagnosis of MTBI is based on symptoms reporting with poor understanding of ongoing pathophysiology, hence precluding prognosis and intervention. Other than rehabilitation, there is still no pharmacological treatment for the treatment of secondary injury and prevention of the development of cognitive and behavioural problems. The lack of external injuries and absence of detectable brain abnormalities lend support to MTBI developing at the cellular and biochemical level. However, the paucity of suitable and validated non-invasive methods for accurate diagnosis of MTBI poses as a substantial challenge. Hence, it is crucial that a clinically useful evaluation and management procedure be instituted for MTBI that encompasses both molecular pathophysiology and functional outcome. The acute microenvironment changes post-MTBI presents an attractive target for modulation of MTBI symptoms and the development of cognitive changes later in life.
⺠This review discusses microenvironment changes after mild brain injury (MTBI). ⺠Preclinical and clinical evidence point towards cellular changes after MTBI. ⺠The microenvironment may explain the decline in behaviour and cognition after MTBI. ⺠Modulation of the injured microenvironment may improve MTBI prognosis.
Journal: Brain Research Bulletin - Volume 87, Issues 4â5, 10 March 2012, Pages 359-372